3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
10
Withdrawn
4
Active not recruiting
4
No longer available
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
venetoclax
38
Azacitidine
24
fludarabine
20
Cytarabine
18
Cyclophosphamide
16
Specimen Handling
14
blinatumomab
13
Biopsy
12
Busulfan
8
Dexamethasone
7
Melphalan
6
Daunorubicin
6
Whole-Body Irradiation
5
Vincristine
5
Thiotepa
5
Methotrexate
5
Decitabine
5
gilteritinib
4
daratumumab
4
Tacrolimus
4
Stem Cell Transplantation
4
Magnetic Resonance Spectroscopy
4
Imatinib Mesylate
4
Idarubicin
4
Exercise
4
Blood Specimen Collection
4
zanubrutinib
3
selinexor
3
ruxolitinib
3
revumenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
navitoclax
×
Other hematologic neoplasm
×
Clear all
NCT05054465
2021-09-23
ITALLI001
Israeli Medical Association
Phase 1/2
Not yet recruiting
48 enrolled